Local Institution

Kaluga 248023

0 studies enrolling now · 3 studies all time

What they study most

Acute Coronary Syndrome, Hepatitis C Virus (HCV), Hepatitis C, Genotype 1

Studies at this site

• Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C — Withdrawn before enrolling